High Temperature Thermal and Vacuum Products Provider Acquired by GT Advanced Technologies

GT Advanced Technologies, today announced that it has acquired substantially all of the business of Thermal Technology LLC for purchase consideration consisting of approximately 3.4 million shares of GTAT common stock and an earn out.

Located in Santa Rosa, CA, Thermal Technology develops and sells a wide range of high temperature thermal and vacuum products used in the fabrication of advanced materials that are deployed across multiple industries including smartphones and touch screens, LED, medical devices, oil and gas and automotive to name a few. Thermal Technology has delivered over 3,000 products to customers in over 40 countries since it was founded 60 years ago.

GT has acquired several key products and technologies that will allow GT to address new markets with a range of production equipment options that can be optimized around customers' specific needs. This includes annealing technology that the company believes will be important in the manufacturing of sapphire cover screens; crystal growth technology based on the Kyropoulous (KY) growth method and edge defined film growth (EFG) technology for large surface area sapphire. The company has also acquired Spark Plasma Sintering (SPS) technology, which allows dense ceramics to be obtained under uniform heating at relatively low temperatures and in short processing times. The SPS technology is expected to have a wide range of applications including with medical applications, sputtering targets, space applications and thermoelectric convertors for hybrid electric cars.

"The acquisition of the Thermal Technology business adds a number of innovative and important products and technologies to our rapidly diversifying portfolio that will, we believe, allow us to accelerate our entrance into new markets," said Tom Gutierrez, GT's president and CEO. "The acquisition expands our served markets and complements several of our current product lines. In areas such as sapphire crystal growth, we can now offer customers a wider range of product options best suited to their specific production environments. This will enable us to compete for incremental business in areas where we would have previously been unable to offer a product."

"This is an exciting moment for the company, our employees and our customers," said Matt Mede, president and CEO of Thermal Technology. "The acquisition will open new opportunities for growth for our products and technology as we integrate them into GT's business operations. Leveraging GT's leadership in engineering and product development and their strengths in low-cost global supply chain management will accelerate the time-to-market of our technology to drive market adoption in several promising markets as we go forward. Customers will also benefit through GT's global service and support capabilities."

GT does not expect the acquisition to materially impact its CY13 revenue or earnings guidance range. The anticipated revenue contribution from the Thermal Technology business in the balance of FY13 is approximately $9 to $14 million. GT expects minimal impact on earnings per share as expenses and the increase in share count will limit the contribution during the initial year of integration.

Friday, May 17, 2013, at 8:00am ET the company will host a conference call with Tom Gutierrez, president and chief executive officer, and Richard Gaynor, chief financial officer, to answer questions about the acquisition. The call will be webcast live and can be accessed by logging on to the "Investors" section of GT Advanced Technologies' website, http://investor.gtat.com/ or by dialing (631) 291-4543. No password is required. A replay of the call will be available. To access the replay, please go to http://investor.gtat.com/ and select the webcast replay link on the 'Events and Presentations' page.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.